Preferential hyperacuity perimetry to detect hydroxychloroquine retinal toxicity

Retina

Volumn 29, Issue 8, 2009, Pages 1188-1192

  Anderson, Carolyn ^a   Pahk, Patricia ^a   Blaha, Gregory R ^a   Spindel, Gerald P ^b   Alster, Yair ^c   Rafaeli, Omer ^c   Marx, Jeffrey L ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b Spindel Eye Associates   (United States)

^c Notal Vision LTD   (Israel)

Author keywords

Chloroquine toxicity; Hydroxychloroquine toxicity; Hyperacuity; Plaquenil; Retinopathy; Toxic maculopathy

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; PERIMETRY; RETINA DISEASE; VISUAL ACUITY; VISUAL FIELD;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MALE; MIDDLE AGED; PILOT PROJECTS; RETINA; RETINAL DISEASES; VISUAL FIELD TESTS;

EID: 70349089058     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181a3b8d4     Document Type: Article

References (11)

1. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF; American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopa-thy. Ophthalmology 2002;109:1377-1382.
2. Easterbrook E. Ocular effects and safety of antimalarial agents. Am J Med 1988;85:23-29.
3. Bernstein HN. Ocular safety of hydroxychloroquine. Ann Ophthalmol 1991;23:292-296.
4. Levy GD, Munz SJ, Paschal J. Incidence of hydroxychloro-quine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum 1997;40:1482-1486.
5. Lee AG. Hydroxychloroquine screening. Br J Ophthalmol 2005;89:521-522.
6. Rodriquez-Padilla JA, Hedges TR III, Monson B, et al. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 2007;125:775-780. (Pubitemid 46919738)
7. Hart WM, Burde RM, Johnston GP, Drews RC. Static perim-etry in chloroquine retinopathy: perifoveal patterns of visual field depression. Arch Ophthalmol 1984;102:377-380.
8. Maturi RK, Yu M, Weleber RG. Multifocal electroretino-graphic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 2004;122:973-981.
9. So SC, Hedges TR, Schuman JS, Quireza ML. Evaluation of hydroxychloroquine retinopathy with multifocal electroreti-nography. Ophthal Surg Laser Imaging 2003;34:251-258.
10. Preferential Hyperacuity Perimetry Research Group. Preferential hyperacuity perimeter (Pre View PHP) for detecting choroidal neovascular study. Ophthalmology 2005;112:1758-1765.
11. Enoch JM, Williams RA, Essock EA, Barricks M. Hyperacuity perimetry: assessment of macular function through ocular opacities. Arch Ophthalmol 1984;102:1164-1168.